Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sleight

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
American Heart Journal|July 31, 2013
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular diseaseMichael Böhm, Helmut Schumacher, Ulrich Laufs, et al.
Journal of Hypertension|March 14, 2014
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysisSébastien Foulquier, Michael Böhm, Roland Schmieder, et al.
Circulation|July 26, 2012
Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)Kai Kappert, Michael Böhm, Roland Schmieder, et al.
BMJ (Clinical Research Ed.)|March 23, 2002
Use of ramipril in preventing stroke: double blind randomised trialJackie Bosch, Salim Yusuf, Janice Pogue, et al.
American Heart Journal|June 25, 2004
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsKoon Teo, Salim Yusuf, Peter Sleight, et al.
European Journal of Heart Failure|July 31, 2007
Clinical relevance of short-term day-time breathing disorders in chronic heart failure patientsMaria Teresa La Rovere, Gian Domenico Pinna, Roberto Maestri, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 2012
Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular diseaseYan Liang, Andrew Mente, Salim Yusuf, et al.
The New England Journal of Medicine|April 2, 2008
Telmisartan, ramipril, or both in patients at high risk for vascular events, Salim Yusuf, Koon K Teo, et al.
Journal of the American College of Cardiology|January 10, 2009
Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking eraMaria Teresa La Rovere, Gian Domenico Pinna, Roberto Maestri, et al.
European Heart Journal|March 17, 2011
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndromeFranz H Messerli, Sripal Bangalore, Harikrishna Makani, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
American Heart Journal|July 31, 2013
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular diseaseMichael Böhm, Helmut Schumacher, Ulrich Laufs, et al.
Journal of Hypertension|March 14, 2014
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysisSébastien Foulquier, Michael Böhm, Roland Schmieder, et al.
Circulation|July 26, 2012
Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)Kai Kappert, Michael Böhm, Roland Schmieder, et al.
BMJ (Clinical Research Ed.)|March 23, 2002
Use of ramipril in preventing stroke: double blind randomised trialJackie Bosch, Salim Yusuf, Janice Pogue, et al.
American Heart Journal|June 25, 2004
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsKoon Teo, Salim Yusuf, Peter Sleight, et al.
European Journal of Heart Failure|July 31, 2007
Clinical relevance of short-term day-time breathing disorders in chronic heart failure patientsMaria Teresa La Rovere, Gian Domenico Pinna, Roberto Maestri, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 2012
Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular diseaseYan Liang, Andrew Mente, Salim Yusuf, et al.
The New England Journal of Medicine|April 2, 2008
Telmisartan, ramipril, or both in patients at high risk for vascular events, Salim Yusuf, Koon K Teo, et al.
Journal of the American College of Cardiology|January 10, 2009
Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking eraMaria Teresa La Rovere, Gian Domenico Pinna, Roberto Maestri, et al.
European Heart Journal|March 17, 2011
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndromeFranz H Messerli, Sripal Bangalore, Harikrishna Makani, et al.
Pageof 9